1.Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B.
Jong Seo HONG ; Chang Seok KI ; Jong Won KIM ; Yeon Lim SUH ; June Soo KIM ; Kyung Kee BAEK ; Byoung Joon KIM ; Kyoung Ju AHN ; Duk Kyung KIM
Journal of Korean Medical Science 2005;20(2):283-290
Emery-Dreifuss muscular dystrophy (EDMD) and limb-girdle muscular dystrophy type 1B (LGMD1B) are characterized by cardiac dysrhythmias, late-onset cardiomyopathy, slowly progressive skeletal myopathy and contractures of the neck, elbows and ankles. The causative mutation is either in the emerin gene (X-linked recessive EDMD) or lamin A/C gene (autosomal dominant EDMD2 or LGMD1B). We report three cases of EDMD, EDMD2 and LGMD1B. A 14-yr-old boy showed limitation of cervical flexion and contractures of both elbows and ankles. Sinus arrest with junctional escape beats was noted. He was diagnosed as X-linked recessive EDMD (MIM 310300). A 28-yr-old female showed severe wasting and weakness of humeroperoneal muscles. Marked limitation of cervical flexion and contractures of both elbows and ankles were noted. Varying degrees of AV block were noted. She was diagnosed as autosomal dominant EDMD2 (MIM 181350). A 41-yr-old female had contractures of both ankles and limb-girdle type muscular dystrophy. ECG revealed atrial tachycardia with high grade AV block. She was diagnosed as autosomal dominant LGMD1B (MIM 159001). Cardiac dysrhythmias in EDMD and LGMD1B include AV block, bradycardia, atrial tachycardia, atrial fibrillation, and atrial standstill, causing sudden death necessitating pacemaker implantation. Cardiologists should know about these unusual genetic diseases with conduction defects, especially in young adults.
Adolescent
;
Adult
;
Arrhythmia/*etiology
;
Cardiomyopathies/*etiology
;
Female
;
Humans
;
Male
;
Muscle, Skeletal/*pathology
;
Muscular Dystrophies,
;
Muscular Dystrophy,
2.Clinical characteristics of 5 Chinese LQTS families and phenotype-genotype correlation.
Jiangfang, LIAN ; Changcong, CUI ; Xiaolin, XUE ; Chen, HUANG ; Hanbin, CUI
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(3):208-11
In order to assess the clinical manifestations and electrocardiogram (ECG) characteristics of Chinese long QT syndrome (LQTS) patients and describe the phenotype-genotype correlation, the subjects from 5 congenital LQTS families underwent clinical detailed examination including resting body surface ECG. QT interval and transmural dispersion of repolarization (TDR) were manually measured. Five families were genotyped by linkage analysis (polymerase chain reacting-short tandem repeat, PCR-STR). The phenotype-genotype correlation was analyzed. Four families were LQT2, 1 family was LQT3. Twenty-eight gene carriers were (14 males and 14 females) identified from 5 families. The mean QTc and TDRc were 0.56 +/- 0.04 s (range 0.42 to 0.63) and 0.16 +/- 0.04 s (range 0.09 to 0.24) respectively. 35.7% (10/28) had normal to borderline QTc (< or = 0.460 s). There was significant difference in QTc and TDRc between the patients with symptomatic LQTS and those with asymptomatic LQTS, and there was significant difference in TDRc between the asymptomatic patients and normal people also. A history of cardiac events was present in 50% (14/28), including 9 with syncope, 2 with sudden death (SD) and occurred in the absence of beta-blocker. Three SDs occurred prior to the diagnosis of LQTS and had no ECG record. Two out of 5 SDs (40%) occurred as the first symptom. Typical LQT2 T wave pattern were found in 40% (6/15) of all affected members. The appearing-normal T wave was found in one LQT3 family. Low penetrance of QTc and symptoms resulted in diagnostic challenge. ECG patterns and repolarization parameters may be used to predict the genotype in most families. Genetic test is very important for identification of gene carriers.
Arrhythmia/etiology
;
Arrhythmia/genetics
;
Asian Continental Ancestry Group
;
Electrocardiography
;
Genotype
;
Long QT Syndrome/complications
;
Long QT Syndrome/congenital
;
Long QT Syndrome/*genetics
;
Pedigree
;
*Phenotype
3.Results of invasive electrophysiologic evaluation in 268 patients with unexplained syncope.
Jiagao, LU ; Zaiying, LU ; Fredrik, VOSS ; Wolfgang, SCHOELS
Journal of Huazhong University of Science and Technology (Medical Sciences) 2003;23(3):278-9
In order to assess the diagnostic value of invasive electrophysiologic study (EPS) in the patients with unexplained syncope, the electrophysiologic findings of 268 patients with unexplained syncope despite a complete clinical evaluation were analyzed. Results showed positive EPS finding was 38% in total patients and 50% in the patients aged > 70 years. With increasing age, the diagnostic yield of EPS also increased. No significant differences of complication rate were found among the different age groups. It was concluded that EPS have high diagnostic value in the patients with unexplained syncope. Its complications are few and mild. EPS may be recommended in elderly patients with unexplained syncope.
Age Factors
;
Arrhythmia/complications
;
Arrhythmia/*diagnosis
;
Diagnosis, Differential
;
*Electrocardiography
;
Electrophysiology
;
Follow-Up Studies
;
Monitoring, Physiologic
;
Retrospective Studies
;
Syncope/diagnosis
;
Syncope/*etiology
;
Tachycardia/complications
;
Tachycardia/diagnosis
4.Drug Induced Hepatitis Mimicking Alcoholic Hepatitis.
The Korean Journal of Hepatology 2006;12(4):574-578
5.Amiodarone-induced Hepatitis and Polyneuropathy.
Hyun Mo KANG ; Yoon Sae KANG ; Seok Hyun KIM ; Jae Kyu SEONG ; Dae Young KANG ; Heon Young LEE ; Byung Seok LEE
The Korean Journal of Internal Medicine 2007;22(3):225-229
Amiodarone chlorhydrate is a diiodated benzofuran derivative, and it is used to treat cardiac rhythm abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone, and symptomatic hepatic dysfunction occurs in fewer than 1% of the patients taking amiodarone. Cirrhosis is a rare complication that's been confirmed in 12 cases. Peripheral neuropathy occurs in 10% of patients taking aminodarone. We report here on an unusual case of amiodarone-induced hepatotoxicity and peripheral neurotoxicity. A 75 year old man with normal liver function was given amiodarone for treating his atrial fibrillation and heart failure. He developed nausea, vomiting, muscle weakness and wasting after 17.8 months therapy with amiodarone (400 mg orally once per day). Liver biopsy showed the presence of foam cells in the hepatic sinusoids and Mallory bodies in the periportal hepatocytes on light microscopy. Sural nerve biopsy showed demyelination, and nerve conduction studies showed mixed sensorimotor polyneuropathy. These observations show the necessity of monitoring the hepatic function and conducting neurologic examination of the patients treated with amiodarone.
Aged
;
Amiodarone/*adverse effects
;
Anti-Arrhythmia Agents/*adverse effects
;
Hepatitis, Toxic/*etiology
;
Humans
;
Liver Cirrhosis/chemically induced
;
Male
;
Polyneuropathies/*chemically induced
6.Establishment of a novel arrhythmia model in rats.
Zhen-Wei PAN ; Zhi-Yong WANG ; Zhi-Min DU ; Jun-Dong JIAO ; De-Li DONG ; Bao-Feng YANG
Acta Pharmaceutica Sinica 2005;40(7):659-662
AIMTo establish a novel arrhythmia model in rats.
METHODSCoronary artery occlusion was produced in hyperlipidemic rats after the animals were fed a high fat and cholesterol chow for 15 days. The incidence, duration and score of arrhythmias were determined 1 hour after coronary occlusion.
RESULTSThe incidence, duration and score of arrhythmia induced by coronary artery occlusion increased significantly in hyperlipidemic rats compared with those in normal rats (P < 0.05). In normal rats, pretreatment with amiodarone 60 mg x kg(-1) or verapamil 25 mg x kg(-1) 3 days before coronary artery occlusion did not influence the incidence, duration and score of arrhythmia (P > 0.05). In hyperlipidemic rats, amiodarone 60 mg x kg(-1) decreased the incidence, duration and score of arrhythmia (P < 0.05), but not verapamil 25 mg x kg(-1) (P > 0.05).
CONCLUSIONThe novel arrhythmia model induced by coronary artery occlusion in hyperlipidemic rats is reliable and similar to the pathophysiological state in human being.
Amiodarone ; pharmacology ; Animals ; Anti-Arrhythmia Agents ; pharmacology ; Arrhythmias, Cardiac ; etiology ; physiopathology ; Coronary Disease ; complications ; Disease Models, Animal ; Hyperlipidemias ; complications ; Male ; Rats ; Rats, Wistar
8.The changes of potassium currents in rabbit ventricle with healed myocardial infarction.
Nian, LIU ; Huiyan, NIU ; Yang, LI ; Cuntai, ZHANG ; Qiang, ZHOU ; Yanfei, RUAN ; Jun, PU ; Zaiying, LU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(2):128-31
To elucidate the mechanism of arrhythmia in healed myocardial infarction (HMI), the changes of action potential duration (APD), transient outward potassium current (Ito), delayed rectifier potassium current (IK) and inward rectifier potassium current (IK1) of left ventricular myocytes in non-infarcted zone of HMI were investigated. Rabbits were randomly assigned into two groups: HMI group, in which animals were subjected to thoracotomy and ligation of the circumflex coronary and sham-operated group, in which rabbits underwent thoracotomy but no conorary ligation. 3 months after the operation, the whole myocyte patch clamp technique was used to record APD, Ito, IK, and IK1 of ventricular myocytes in non-infarcted zone. Our results showed that the membrane capacitance was larger in HMI group than in sham-operated group. Action potential duration was significantly lengthened in HMI group and early afterdepolarization (EAD) appeared in HMI group. The densities of Ito, I(K, tail), and IK1 were reduced significantly in HMI group, from 6.72 +/- 0.42 pA/pF, 1.54 +/- 0.13 pA/pF and 25.6 +/- 2.6 pA/pF in sham-operated group to 4.03 +/- 0.33 pA/pF, 1.14 +/- 0.11 pA/pF and 17.6 +/- 2.3 pA/pF, respectively. It is concluded that the reduced densities of Ito, I(K, tail) and IK1 in ventricular myocytes of non-infarcted zone in HMI were responsible for the prolongation of APD and the presentation of EAD which played important roles in the development of malignant arrhythmia in HMI.
Action Potentials
;
Arrhythmia/*etiology
;
Heart Ventricles/metabolism
;
Myocardial Infarction/complications
;
Myocardial Infarction/metabolism
;
Myocardial Infarction/*pathology
;
Myocytes, Cardiac/*cytology
;
Patch-Clamp Techniques
;
Potassium Channels/*metabolism
9.Complications of 2-D Echocardiography Guided Transfemoral Right Ventricular Endomyocardial Biopsy.
Juyup HAN ; Yongwhi PARK ; Hyunsang LEE ; Hyunjae KANG ; Hyungseop KIM ; Dong Heon YANG ; Hun Sik PARK ; Yongkeun CHO ; Shung Chull CHAE ; Jae Eun JUN ; Wee Hyun PARK
Journal of Korean Medical Science 2006;21(6):989-994
Endomyocardial biopsy (EMBx) is a useful tool for diagnosing various cardiac pathologies. However, the routine use of EMBx has not gained widespread acceptance due to the possible complications related to the EMBx. Thus, not much information is available on the complications related to the EMBx. We prospectively evaluated 90 consecutive patients who underwent 2-D echocardiography guided transfemoral right ventricular EMBx at Kyungpook National University Hospital between March 2002 and November 2005 to determine the incidence, nature and subsequent management of complications related to EMBx. The clinical diagnoses before the EMBx were arrhythmogenic right ventricular dysplasia in 54, dilated cardiomyopathy in 19, Brugada syndrome in 9, myocarditis in 6 and miscellaneous in 2 patients. The overall major complication rate was 5.6% and no procedure-related mortality occurred. Myocardial perforation (n=3), which was the most frequent complication, did not progress to cardiac tamponade requiring pericardiocentesis in any patient. Hemodynamically unstable ventricular tachycardia occurred in 1 patient. New and persistent right bundle branch block occurred in another. Our findings suggest that 2-D echocardiography guided transfemoral right ventricular EMBx is a relatively safe procedure.
Wounds, Penetrating/*etiology/ultrasonography
;
Treatment Outcome
;
Surgery, Computer-Assisted/methods
;
Middle Aged
;
Male
;
Humans
;
Heart Ventricles/injuries/*pathology/*ultrasonography
;
Heart Injuries/*etiology/ultrasonography
;
Female
;
Endocardium/injuries/pathology
;
Echocardiography/methods
;
Biopsy, Needle/*adverse effects
;
Arrhythmia/*etiology/*ultrasonography
10.Complications of 2-D Echocardiography Guided Transfemoral Right Ventricular Endomyocardial Biopsy.
Juyup HAN ; Yongwhi PARK ; Hyunsang LEE ; Hyunjae KANG ; Hyungseop KIM ; Dong Heon YANG ; Hun Sik PARK ; Yongkeun CHO ; Shung Chull CHAE ; Jae Eun JUN ; Wee Hyun PARK
Journal of Korean Medical Science 2006;21(6):989-994
Endomyocardial biopsy (EMBx) is a useful tool for diagnosing various cardiac pathologies. However, the routine use of EMBx has not gained widespread acceptance due to the possible complications related to the EMBx. Thus, not much information is available on the complications related to the EMBx. We prospectively evaluated 90 consecutive patients who underwent 2-D echocardiography guided transfemoral right ventricular EMBx at Kyungpook National University Hospital between March 2002 and November 2005 to determine the incidence, nature and subsequent management of complications related to EMBx. The clinical diagnoses before the EMBx were arrhythmogenic right ventricular dysplasia in 54, dilated cardiomyopathy in 19, Brugada syndrome in 9, myocarditis in 6 and miscellaneous in 2 patients. The overall major complication rate was 5.6% and no procedure-related mortality occurred. Myocardial perforation (n=3), which was the most frequent complication, did not progress to cardiac tamponade requiring pericardiocentesis in any patient. Hemodynamically unstable ventricular tachycardia occurred in 1 patient. New and persistent right bundle branch block occurred in another. Our findings suggest that 2-D echocardiography guided transfemoral right ventricular EMBx is a relatively safe procedure.
Wounds, Penetrating/*etiology/ultrasonography
;
Treatment Outcome
;
Surgery, Computer-Assisted/methods
;
Middle Aged
;
Male
;
Humans
;
Heart Ventricles/injuries/*pathology/*ultrasonography
;
Heart Injuries/*etiology/ultrasonography
;
Female
;
Endocardium/injuries/pathology
;
Echocardiography/methods
;
Biopsy, Needle/*adverse effects
;
Arrhythmia/*etiology/*ultrasonography